CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma

Acta Neuropathologica

Volumn 124, Issue 1, 2012, Pages 99-110

  Smith, Stuart J ^a,b   Tilly, Hanna ^a   Ward, Jennifer H ^a   Macarthur, Donald C ^b   Lowe, James ^b   Coyle, Beth ^a   Grundy, Richard G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Angiogenesis; CD133; Endoglin; Glioblastoma

Indexed keywords

CD133 ANTIGEN; ENDOGLIN;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENPP5 GENE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULARIZATION; MIRROR IMAGE POLYDACTYLY 1 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD31; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84862772940     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0952-1     Document Type: Article

References (50)

1. Batchelor TT, Duda DG, di Tomaso E et al (2010) Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol 28:2817-2823
2. Behrem S, Zarkovic K, Eskinja N, Jonjic N (2005) Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat Med J 46:417-422
3. Beier D, Wischhusen J, Dietmaier W et al (2008) CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 18:370-377
4. Benesch M, Wagner S, Berthold F, Wolff JE (2005) Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). J Neurooncol 72:179-183
5. Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl) 86:1025-1032
6. Birlik B, Canda S, Ozer E (2006) Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Neuropathol Appl Neurobiol 32:532-538
7. Brem S, Cotran R, Folkman J (1972) Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48:347-356
8. Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82
9. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749
10. Charles N, Ozawa T, Squatrito M et al (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6:141-152
11. Chen J, Watanabe M, Huang P et al (2009) REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells. Int J Mol Med 24:789-794
12. Cheung AK, Lung HL, Ko JM et al (2009) Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma. Proc Natl Acad Sci USA 106:14478-14483
13. Christensen K, Schroder HD, Kristensen BW (2008) CD133 identifies perivascular niches in grade II-IV astrocytomas. J Neurooncol 90:157-170
14. Dohrmann GJ, Farwell JR, Flannery JT (1985) Astrocytomas in childhood: a population-based study. Surg Neurol 23:64-68
15. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984-992
16. Folkman J (2006) Angiogenesis. Annu Rev Med 57:1-18
17. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumorassociated angiogenetic blood vessels. Oncogene 22:6557-6563
18. Fonsatti E, Nicolay HJ, Altomonte M, Covre A, Maio M (2009) Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res 86:12-19
19. Germano A, Caffo M, Caruso G et al (2001) A preliminary study of angiogenesis in paediatric glioblastoma multiforme and its correlation with survival. Childs Nerv Syst 17:577-583
20. Hagiwara S, Murakumo Y, Mii S et al (2010) Processing of CD109 by furin and its role in the regulation of TGF-beta signaling. Oncogene 29:2181-2191
21. Hagiwara S, Murakumo Y, Sato T et al (2008) Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity. Cancer Sci 99:1916-1923
22. Hashimoto M, Ichihara M, Watanabe T et al (2004) Expression of CD109 in human cancer. Oncogene 23:3716-3720
23. Hockla A, Radisky DC, Radisky ES (2009) Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res Treat 124:27-38
24. Jaksch M, Munera J, Bajpai R, Terskikh A, Oshima RG (2008) Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 68:7882-7886
25. Kamnasaran D, O'Brien PC, Zackai EH et al (2003) Rearrangement in the PITX2 and MIPOL1 genes in a patient with a t(4;14) chromosome. Eur J Hum Genet 11:315-324
26. Kondoh S, Sugawara H, Harada N et al (2002) A novel gene is disrupted at a 14q13 breakpoint of t(2;14) in a patient with mirror-image polydactyly of hands and feet. J Hum Genet 47:136-139
27. Lebrin F, Srun S, Raymond K et al (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16:420-428
28. Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372
29. Li C, Issa R, Kumar P et al (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116:2677-2685
30. Liu S, Murph M, Panupinthu N, Mills GB (2009) ATX-LPA receptor axis in inflammation and cancer. Cell Cycle 8:3695-3701
31. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
32. McCord AM, Jamal M, Shankavaram UT et al (2009) Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 7:489-497
33. Murray LJ, Bruno E, Uchida N et al (1999) CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells. Exp Hematol 27:1282-1294
34. Netto GC, Bleil CB, Hilbig A, Coutinho LM (2008) Immuno-histochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Neuropathology 28:17-23
35. Paugh BS, Qu C, Jones C et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061-3068
36. Pelegrini AL, Moura DJ, Brenner BL et al (2010) Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest. Mutagenesis 25:447-454
37. Rahman R, Smith S, Rahman C, Grundy R (2010) Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma. J Oncol 2010:251231
38. Reinmuth N, Piegelbrock E, Raedel M et al (2007) Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer. Lung Cancer 55:53-60
39. Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824-828
40. Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91
41. Smith SJ, Long A, Barrow JH et al (2011) Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target. Neuro Oncol 13(11):1171-1177
42. Soda Y, Marumoto T, Friedmann-Morvinski D et al (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108:4274-4280
43. Vaidya SJ, Hargrave D, Saran F et al (2007) Pattern of recurrence in paediatric malignant glioma: an institutional experience. J Neurooncol 83:279-284
44. Vranic A, Popovic M, Cor A, Prestor B, Pizem J (2010) Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124-1132
45. Wang R, Chadalavada K, Wilshire J et al (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829-833
46. Williams RF, Sims TL, Tracey L et al (2010) Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells. Anticancer Res 30:3301-3308
47. Yao Y, Kubota T, Takeuchi H, Sato K (2005) Prognostic significance of microvessel density determined by an anti-CD105/ endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25:201-206
48. Yoon KW, Cho JH, Lee JK et al (2009) CIB1 functions as a Ca(2+)-sensitive modulator of stress-induced signaling by targeting ASK1. Proc Natl Acad Sci USA 106:17389-17394
49. Zhu T, Costello MA, Talsma CE et al (2011) Endothelial cells create a stem cell niche in glioblastoma by providing Notch ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 71(18):6061-6072
50. Zijlmans HJ, Fleuren GJ, Hazelbag S et al (2009) Expression of endoglin (CD105) in cervical cancer. Br J Cancer 100:1617-1626